The first FDHT-PET imaging of AR in men with advanced prostate cancer was published together with my colleagues at Washington University Medical School [3] and nearly simultaneously by investigators at Sloan Kettering Cancer Center [115]. This evidence concerns the gene AR and prostate cancer.